The progress of angiogenic factors in the development of leukemias.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Intractable & Rare Diseases Research

• Publication date

  2016-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.5582/irdr.2015.01048PMID 26989643PMCID PMC4761589
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Matrix metalloproteinases in bone marrow : roles of gelatinases in physiological hematopoiesis and hematopoietic malignancies

  2017cited by this paper
• Heparan Sulfate D‐Glucosaminyl 3‐O‐Sulfotransferase‐3B1 (HS3ST3B1) Promotes Angiogenesis and Proliferation by Induction of VEGF in Acute Myeloid Leukemia Cells

  2015cited by this paper
• Epigenetic Therapy in Acute Myeloid Leukemia: Current and Future Directions.

  2015cited by this paper
• Phase 1 dose escalation trial of ilorasertib, a dual Aurora/VEGF receptor kinase inhibitor, in patients with hematologic malignancies

  2015cited by this paper
• Angiogenic factors in chronic lymphocytic leukaemia (CLL): Where do we stand?

  2015cited by this paper
• Functional interaction between CTGF and FPRL1 regulates VEGF-A-induced angiogenesis.

  2015cited by this paper
• Social defeat stress promotes tumor growth and angiogenesis by upregulating vascular endothelial growth factor/extracellular signal-regulated kinase/matrix metalloproteinase signaling in a mouse model of lung carcinoma.

  2015cited by this paper
• A phase II study of AZD2171 (cediranib) in the treatment of patients with acute myeloid leukemia or high-risk myelodysplastic syndrome

  2015cited by this paper
• Identification of a novel E-box binding pyrrole-imidazole polyamide inhibiting MYC-driven cell proliferation

  2015cited by this paper
• Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling

  2015cited by this paper
• Ginsenoside Rg3 inhibits HIF-1α and VEGF expression in patient with acute leukemia via inhibiting the activation of PI3K/Akt and ERK1/2 pathways.

  2014cited by this paper
• Angiogenesis and acute myeloid leukemia

  2014cited by this paper
• In Vitro Characterization of Valproic Acid, ATRA, and Cytarabine Used for Disease-Stabilization in Human Acute Myeloid Leukemia: Antiproliferative Effects of Drugs on Endothelial and Osteoblastic Cells and Altered Release of Angioregulatory Mediators by Endothelial Cells

  2014cited by this paper
• Serum levels of angiopoietin-2, but not angiopoietin-1, are elevated in patients with erythrodermic cutaneous T-cell lymphoma.

  2014cited by this paper
• Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia.

  2014influential reference
• Novel Approach for Coexpression Analysis of E2F1–3 and MYC Target Genes in Chronic Myelogenous Leukemia

  2014cited by this paper
• (Lymph)angiogenic influences on hematopoietic cells in acute myeloid leukemia

  2014cited by this paper
• Restoration of natural killer cell cytotoxicity by VEGFR-3 inhibition in myelogenous leukemia.

  2014cited by this paper
• Vascular endothelial growth factor-C modulates proliferation and chemoresistance in acute myeloid leukemic cells through an endothelin-1-dependent induction of cyclooxygenase-2.

  2014cited by this paper
• Activation of the vascular niche supports leukemic progression and resistance to chemotherapy.

  2014cited by this paper
• Angiogenesis in myeloproliferative neoplasms, new markers and future directions

  2014cited by this paper
• Role of tumour angiogenesis in haematological malignancies.

  2014influential reference
• Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia.

  2014cited by this paper
• Ponatinib overcomes FGF2-mediated resistance in CML patients without kinase domain mutations.

  2014cited by this paper
• Insights in Hodgkin Lymphoma angiogenesis.

  2014cited by this paper
• Epidermal growth factor receptor variant type III markedly accelerates angiogenesis and tumor growth via inducing c-myc mediated angiopoietin-like 4 expression in malignant glioma

  2013cited by this paper
• The VEGF receptor, neuropilin‐1, represents a promising novel target for chronic lymphocytic leukemia patients

  2013influential reference
• Antitumor activity of a pyrrole-imidazole polyamide

  2013cited by this paper
• The angiopoietin:Tie 2 interaction: a potential target for future therapies in human vascular disease.

  2013cited by this paper
• Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: an overview.

  2013cited by this paper
• Role of c-MYC in tumor-associated macrophages and cancer progression

  2013cited by this paper
• Structural basis for angiopoietin-1–mediated signaling initiation

  2013cited by this paper
• ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia

  2013cited by this paper
• Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5

  2013cited by this paper
• Valproic acid inhibits tumor angiogenesis in mice transplanted with Kasumi-1 leukemia cells

  2013cited by this paper
• Activity of a Py–Im Polyamide Targeted to the Estrogen Response Element

  2013cited by this paper
• Matrix Metalloproteinase-13 (MMP-13) Directly and Indirectly Promotes Tumor Angiogenesis*

  2012cited by this paper
• Gene expression changes in a tumor xenograft by a pyrrole-imidazole polyamide

  2012cited by this paper
• Role of VEGF/VEGFR in the pathogenesis of leukemias and as treatment targets (Review).

  2012cited by this paper
• Crystal structure of human angiogenin with an engineered loop exhibits conformational flexibility at the functional regions of the molecule

  2012cited by this paper
• HIF-1α downregulates miR-17/20a directly targeting p21 and STAT3: a role in myeloid leukemic cell differentiation

  2012cited by this paper
• Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology.

  2012cited by this paper
• The hallmarks of cancer

  2012cited by this paper
• Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment

  2012cited by this paper
• Pro-apoptotic activity of inhibitory PAS domain protein (IPAS), a negative regulator of HIF-1, through binding to pro-survival Bcl-2 family proteins

  2011cited by this paper
• BET bromodomain inhibition as a therapeutic strategy to target c-Myc.

  2011cited by this paper
• High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes

  2011cited by this paper
• Foretinib demonstrates anti-tumor activity and improves overall survival in preclinical models of hepatocellular carcinoma

  2011influential reference
• Evidence for a macromolecular complex in poor prognosis CLL that contains CD38, CD49d, CD44 and MMP‐9

  2011influential reference
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• MMP inhibition blocks fibroblast-dependent skin cancer invasion, reduces vascularization and alters VEGF-A and PDGF-BB expression.

  2010cited by this paper
• Hypoxia increases HIF-1α expression and constitutive cytokine release by primary human acute myeloid leukaemia cells.

  2010cited by this paper
• The crosstalk between the matrix metalloprotease system and the chemokine network in acute myeloid leukemia.

  2010cited by this paper
• Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF.

  2010cited by this paper
• Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation

  2010cited by this paper
• Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia.

  2009cited by this paper
• Genomics, environmental genomics and the issue of microbial species

  2008cited by this paper
• c-Myc and eIF4F are components of a feedforward loop that links transcription and translation.

  2008cited by this paper
• Mechanisms of action of angiogenin.

  2008cited by this paper
• Global Regulation of Nucleotide Biosynthetic Genes by c-Myc

  2008cited by this paper
• Release of angiopoietin-1 by primary human acute myelogenous leukemia cells is associated with mutations of nucleophosmin, increased by bone marrow stromal cells and possibly antagonized by high systemic angiopoietin-2 levels

  2008cited by this paper
• Hypoxia-inducible factor-1α-induced differentiation of myeloid leukemic cells is its transcriptional activity independent

  2008cited by this paper
• Matrix metalloproteinases as valid clinical targets.

  2007cited by this paper
• Coordinated vascular endothelial growth factor expression and signaling during skeletal myogenic differentiation.

  2007cited by this paper
• VEGF-D is expressed in activated lymphoid cells and in tumors of hematopoietic and lymphoid tissues

  2007cited by this paper
• Regulation of matrix metalloproteinase gene expression

  2007cited by this paper
• Hypoxia: A key regulator of angiogenesis in cancer

  2007cited by this paper
• Evaluation of HIF-1 inhibitors as anticancer agents.

  2007cited by this paper
• Angiopoietin-1, 2 and Tie2 expressions in endometrial adenocarcinoma--the Ang2 dominant balance up-regulates tumor angiogenesis in the presence of VEGF.

  2006cited by this paper
• Hypoxia-Inducible Factor-1 (HIF-1)

  2006cited by this paper
• Hypoxia inducible factor-1alpha and leukemic cell differentiation.

  2006cited by this paper
• Vascular endothelial growth factor delays onset of failure in pressure–overload hypertrophy through matrix metalloproteinase activation and angiogenesis

  2006cited by this paper
• Comparative integromics on Angiopoietin family members.

  2006cited by this paper
• Hypoxic Regulation of Vascular Endothelial Growth Factor through the Induction of Phosphatidylinositol 3-Kinase/Rho/ROCK and c-Myc*

  2006cited by this paper
• Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma.

  2006cited by this paper
• Matrix metalloproteinases in bone marrow: roles of gelatinases in physiological hematopoiesis and hematopoietic malignancies.

  2006cited by this paper
• Regulation of angiogenesis by hypoxia-inducible factor 1.

  2006cited by this paper
• Role of Matrix Metalloproteinase-7 (Matrilysin) in Human Cancer Invasion, Apoptosis, Growth, and Angiogenesis

  2006cited by this paper
• Inconsistent effects of acidosis on HIF-alpha protein and its target genes.

  2006cited by this paper
• Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster

  2006cited by this paper
• The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta.

  2006cited by this paper
• Earlier onset of tumoral angiogenesis in matrix metalloproteinase-19-deficient mice.

  2006cited by this paper
• Plasma concentrations of vascular endothelial growth factor and basic fibroblast growth factor in lymphoproliferative disorders.

  2005cited by this paper
• Hypoxia-inducible factor-1 (HIF-1).

  2005cited by this paper
• Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis.

  2005cited by this paper
• Inconsistent effects of acidosis on HIF-α protein and its target genes

  2005cited by this paper
• Beta-catenin regulates the gene of MMP-26, a novel metalloproteinase expressed both in carcinomas and normal epithelial cells.

  2004cited by this paper
• β-Catenin regulates the gene of MMP-26, a novel matrix metalloproteinase expressed both in carcinomas and normal epithelial cells

  2004cited by this paper
• The biology of VEGF and its receptors

  2003cited by this paper
• Cobalt chloride and low oxygen tension trigger differentiation of acute myeloid leukemic cells: possible mediation of hypoxia-inducible factor-1α

  2003cited by this paper
• Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2

  2003cited by this paper
• Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor.

  2003cited by this paper
• Topotecan inhibits VEGF‐ and bFGF‐induced vascular endothelial cell migration via downregulation of the PI3K‐Akt signaling pathway

  2002cited by this paper
• Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis.

  2001cited by this paper
• HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing

  2001cited by this paper
• [Angiogenin: involvement in angiogenesis and tumour growth].

  2001cited by this paper
• Vascular Endothelial Growth Factor and Angiopoietin-1 Stimulate Postnatal Hematopoiesis by Recruitment of Vasculogenic and Hematopoietic Stem Cells

  2001cited by this paper
• Specific collagenolysis by gelatinase A, MMP‐2, is determined by the hemopexin domain and not the fibronectin‐like domain

  2001cited by this paper
• L'angiogénine : implication dans l'angiogenèse et le développement tumoral

  2001cited by this paper
• Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias

  2001cited by this paper

• AdipoRon promotes angiogenesis in B-cell leukemia by modulating pro-angiogenic factors through AdipoR1

  2025cites this paper
• Inflammation mediated angiogenesis in chronic lymphocytic leukemia

  2024cites this paper
• An overview of the molecular and clinical significance of the angiopoietin system in leukemia

  2023cites this paper
• The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways

  2023cites this paper
• A comprehensive insight into the role of molecular pathways affected by the Angiopoietin and Tie system involved in hematological malignancies' pathogenesis.

  2023cites this paper
• Phosphoinositide 3-Kinase Signaling in the Tumor Microenvironment: What Do We Need to Consider When Treating Chronic Lymphocytic Leukemia With PI3K Inhibitors?

  2021cites this paper
• CD44 enhances adriamycin resistance in chronic myelogenous leukaemia cells K562

  2021cites this paper
• Tumor grafted – chick chorioallantoic membrane as an alternative model for biological cancer research and conventional/nanomaterial-based theranostics evaluation

  2021cites this paper
• Vascular Endothelial Growth Factor-A Plasma Level and-460 VEGF Gene Single Nucleotide Polymorphism Significance in Childhood Acute Lymphoblastic Leukemia in Basrah, Iraq

  2021cites this paper
• Investigating the expression pattern of the angiopoietin-Tie system in ALL and its correlation with baseline characteristics

  2021influential citation
• Targeting PI3K/Akt signal transduction for cancer therapy

  2021cites this paper
• Modulating barriers of tumor microenvironment through nanocarrier systems for improved cancer immunotherapy: a review of current status and future perspective

  2020cites this paper
• The Significance of Inflammatory Markers in the Prognosis of Newly Diagnosed Multiple Myeloma Patients

  2020cites this paper
• Neoangiogenesis and microvascular density in myelodysplastic syndrome – a single center experience

  2019cites this paper
• Acute Myeloid Leukemia and the Bone Marrow Niche—Take a Closer Look

  2018cites this paper
• Allium Roseum L. Extract Exerts Potent Suppressive Activities on Chronic Myeloid Leukemia K562 Cell Viability Through the Inhibition of BCR-ABL, PI3K/Akt, and ERK1/2 Pathways and the Abrogation of VEGF Secretion

  2017cites this paper
• Microvessel Density as a Surrogate Prognostic Marker in Patients with Multiple Myeloma: A Meta-Analysis

  2017cites this paper
• An Updated Portrait of Pathogenesis, Molecular Markers and Signaling Pathways of Hepatocellular Carcinoma.

  2017cites this paper
• Anti-Carcinogenic Effects of Carnosol-An Updated Review.

  2017cites this paper
• Post-transcriptional regulation of cytokine and growth factor signaling in cancer.

  2017cites this paper
• Bone Marrow Blood Vessels: Normal and Neoplastic Niche

  2016cites this paper